A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.

A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.

scientific article

Author/s

Work details

Publication date: March 14, 2014

Language: English

Country of origin: Unknown

Copyright status

Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.

To learn more about copyright terms in different countries, visit the countries and terms page.